The Global Immunoglobulin Market garnered $9.9 billion in 2017 and is projected to attain $16.7 billion by 2025, growing at a CAGR of 6.6% during the forecast period, 2018-2025.
Based on region, the immunoglobulin market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is the largest contributor toward the global market, followed by Asia-Pacific. These regions collectively occupy almost 75% of the global market revenue. Presence of the largest plasma production facilities and high adoption rate in the developed countries majorly boost the market growth. However, LAMEA is projected to register the highest growth rate during the forecast period.
Download Report Sample Copy @ https://www.alliedmarketresearch.com/request-sample/2586
Increase in prevalence of immunodeficiency diseases, growth in occurrences of bleeding disorders, rise in geriatric population, and the surge in adoption of immunoglobulin drive the growth of the global immunoglobulin market. Additionally, the development of cost-effective therapeutics through large-scale production would create lucrative opportunities for new market players, especially in emerging economies. However, high therapeutic cost and strict government regulations restrict market growth in the future.
The report segments the global immunoglobulin market based on application, product, mode of delivery, and geography. Based on application, the market is categorized into hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy, immunodeficiency disease, myasthenia gravis, multifocal motor neuropathy, idiopathic thrombocytopenic purpura, inflammatory myopathies, specific antibody deficiency, Guillain-Barre syndrome, and others. Owing to a large patient population and lack of effective substitute treatment, the hypogammaglobulinemia segment contributed maximum revenue to the global market in 2016 and is expected to maintain dominance through 2025. However, the myasthenia gravis segment is projected to encounter the highest growth rate during the forecast period.
The report also sub-segments the market into IgG, IgA, IgM, IgE, and IgD, based on product. Based on mode of delivery, the market is bifurcated into intravenous and subcutaneous. Regionally, North America dominated global immunoglobulins market owing to high adoption rate and the presence of large plasma production facilities. However, the LAMEA region is expected to grow at the fastest rate, registering a CAGR of 9.4%.
For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/2586
The report also profiles key players involved in the global immunoglobulin market, such as
- Baxter International Inc.,
- CSL Ltd.,
- Grifols S.A,
- Octapharma AG,
- Kedrion Biopharma Inc.,
- LFB group,
- Biotest AG,
- China Biologics Products, Inc.,
- Shire (Baxalta), and Bayer Healthcare.
They have adopted various strategies such as mergers & acquisitions, collaborations, partnerships, and others to gain a strong position in the industry.
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060